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Abstract
In our society, an individual’s worth is tied to the state of their cognitive function which
affects the discourse about neurodegenerative illnesses, causing it to mostly fall under two
branches: “The Dread” and “Science as the Holy Grail”. “The Dread” addresses how
Alzheimer’s Disease (AD) and other dementias are typically perceived as devastating illnesses to
be feared. “Science as the Holy Grail” represents the hope and faith that is invested into potential
technoscientific developments without the guarantee of any consequential results. Limiting the
narrative to these two categories negatively impacts the quality of life (QOL) of AD patients,
caregivers, and families. Disciplines such as music, art, and literature, are not traditionally
consulted as ways of helping AD patients and caregivers. The majority of resources available for
AD and dementia are designated to support scientific studies and research projects that anticipate
the development of solutions in the future. Putting monetary and labor resources into science has
been disappointing so far. It is unlikely that the humanities will find the cure for dementia but
investing time and energy into alternative approaches could yield some real time solutions
directed towards improving QOL for AD and dementia patients and caregivers. Through analysis
of a graphic novel and an artist’s self portraits, I honed in on some of the ways that people
affected by AD and dementia could really benefit from what the humanities has to offer and to
showcase what different humanities-based therapies have already been able to achieve for
dementia patients.
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Preface
My grandmother was my everything. She played a huge role in raising me. My mom was
a single mom and she was the breadwinner of the household. That meant that it was just me and
my grandma most of the time, until age five when I started going to school. When I was fifteen,
my grandmother started to experience symptoms of Lewy Body dementia (LBD). The onset of
her condition was especially hard to accept. No one in my household understood what was
happening. My mom and I thought my grandmother was messing with us. We thought she was
doing weird things on purpose. Sometimes we would laugh but other times we would get angry.
It was complicated and painful for the three of us.
Eventually, my grandma was diagnosed and new challenges arose. New challenges arise
to this day. It’s been seven years. My mom and I still grieve. Grieving someone who is still alive
is a pain unlike no other. It is heavy and consistent. There is no moving on. There is no comfort
in the idea that she might be in a better place now because she is still here with us. You have to
deal with your pain every day; it just so happens that your pain stems from someone you love,
that you don’t know anymore, that has become someone else. You drive yourself crazy doing the
things she can’t do anymore: thinking and remembering. Thinking of potential whys, reasons,
and solutions. Remembering her wisdom, her warmth, her laughter. You think to yourself “she is
still alive so there must be something we can do.” But there isn’t. That doesn’t stop you from,
metaphorically, banging your head against the wall to see if one day, if you just think hard
enough you might come up with something to fix it.
Acceptance is difficult. It never really comes but if it does, it only visits. Acceptance is
temporary and often happens when you are tired. Tired of thinking and remembering. Tired of
feeling sad or angry. So, you decide to give acceptance a try and attempt to cope. But, just when
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you think you’ve figured out the whole acceptance and coping thing, you might remember a
moment or see an old photograph. A wave of sadness will take over and you are left not knowing
what to do with yourself. For me, not knowing what to do with myself usually manifests into an
idea or action.
The first time I had an “idea”, I was sixteen. I decided that I wanted to raise money for
the Alzheimer’s Association (AA). I really believed in their mission and I wanted to start my
own fundraiser. And I did. I made my own fundraising page. I posted about it on my social
media accounts and I talked about it every chance I got. By the end of it, I was able to raise $100.
To me, this was huge. $100 was a lot of money to me. It still is. I felt empowered because I did it
all on my own. People in my immediate family didn’t believe in what I was doing. They told me
I wasn’t going to meet my fundraising goal and they ended up being wrong. This was my way of
making a small difference and I did it for my grandmother. I did it because I believe in science. I
believe in the power of research and I hope that one day the AA’s goal of ending dementia comes
to fruition.
I have been on the AA’s emailing list for many years. All of their emails are structured
similarly. They’ll include a cute or devastating story about a family who has a loved one with
Alzheimer’s, they’ll tell you about the latest scientific research findings, and they’ll end the
email by asking you to donate money. After so many years of receiving these emails, they can
get kind of annoying. Sometimes, reading them feels like a slap in the face. Before continuing,
please know that my intent is not to bash the AA. I actually think they do great work. My intent
is only to tell the origin story of this thesis paper, also known as my second “idea”.
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The one email that really was the catalyst for initial conversations about this project was
from Harry Johns, the CEO of the AA, on July 12th, 2021 (see fig. 1). This email served to
announce the FDA’s approval of aducanumab, or Aduhelm. Aduhelm is the first ever FDA
approved treatment that actually addresses Alzheimer’s Disease (AD) itself (see fig. 1). Other
AD medications prior have only been able to address the symptoms of the disease. Johns
continues his letter by telling us how Biogen, the company responsible for developing Aduhelm,
is charging AD patients $56,000 annually for their drug (see fig. 1). The fact that pharmaceutical
companies can charge an absurd amount of money for medications that many people could really
benefit from is atrocious. That could be the topic of a whole other thesis paper and is certainly
not within the jurisdiction of the AA. At the same time, it is known that the AA works to
increase the amount of funding that the government allocates towards AD research every year.
With the $3.2 billion that the National Institutes of Health (NIH) is expected to spend on AD
research in 2021 alone, one would think that there would be more treatment options for AD
patients (Alzheimer’s Association). Instead, we have a single medication that most AD patients
would not be able to access anyway. Given this context, one might understand why it is
disappointing or frustrating to receive emails that brag about new and exciting scientific findings
that give us hope for the future, immediately followed by the request for donations, time and
time again.
The reason why these emails feel disrespectful is because they don’t address the everyday
problems. Science is often focused on finding solutions to “big” problems. The “big” problem in
this case is the need to cure neurodegenerative diseases like AD. Science is not concerned with
the “little” problems that patients and caregivers face on a daily basis. The reality is that these
“little” problems feel really big to us. They feel insurmountable and lonely. An example of a
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“little” problem could be the grief I was describing earlier. Science cannot alleviate that but there
are other things that can.
During my first semester of college, I was looking for another way to put my pain to
good use. I wasn’t interested in fundraising for the AA anymore. On my quest for an outlet, I
came across a volunteer group called Colby Legacy Storytellers. Every week, my volunteer
partner and I would visit a local assisted living facility and we would speak to an assigned
patient, who I’ll call Mary. Mary was in the preliminary stages of AD. Our job was to ask Mary
questions that would prompt her to tell us about her life and we would record these
conversations. Towards the end of the semester, we transcribed these sessions, wrote a story, and
found pictures to include in a little book about Mary’s life. At an end-of-the-year celebration, my
partner and I got to meet Mary’s family (with Mary in attendance) and present them with the
book we made to document Mary’s life. We read the book out loud together. I watched Mary’s
relatives smile, laugh, and some even got emotional. There was power in the narrative my
partner and I wrote. It is a tangible record of the wonderful person that Mary was and the
awesome life she lived. It is something Mary’s family will always have and be able to refer back
to as Mary’s illness progresses.
Volunteering with Colby Legacy Storytellers was one of the best experiences of my life.
What I was able to do for Mary’s family was something I desperately would have wanted
someone to do for my family during the early stages of my grandmother’s prognosis. It would
have provided great comfort to my mom and I when we needed it most. I tell this anecdote only
to describe an act that was not very scientific at all but yielded great results, nonetheless.
Storytelling and photography are examples of cultural productions that are highly likely to
provide relief when one is experiencing tremendous loss or hardship. Yet, it is uncommon to turn
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to such cultural productions as a line of defense. Instead, we heavily rely on science to somehow
produce the relief we so desire, through invention, discovery, or the acquisition of knowledge,
which are all much less likely to occur. I write to illuminate how backwards this is and how
shifting our focus, at least partially, to the humanities could significantly improve the quality of
life (QOL) of so many patients, caregivers, and families.
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Introduction
Music, art, and literature, are resources that are not often highlighted as ways of helping
AD patients and caregivers. In this paper, I argue that it would be a good use of the time and
energy available to AD patients, and the personal and medical communities surrounding them, to
increase accessibility to humanities-based resources. Through analysis of a graphic novel and an
artist’s self portraits, I hope to hone in on some of the ways that AD and dementia patients and
caregivers could really benefit from what humanities genres have to offer. Most, if not all, of the
money for AD and dementia goes to funding different scientific studies and research projects that
will develop solutions for us in the future. Instead of putting everything we have (i.e. funding and
faith) into science, it might be wise to allocate some of those resources into the humanities. One
of my primary goals in the writing of this thesis is to showcase what different humanities-based
therapies have been able to achieve for dementia patients and to emphasize how leaving such
therapies out of care plans is doing these patients an enormous disservice.While the arts, for
instance, will likely be unable to find a concrete cure for dementia, they could yield some real
time solutions by improving the QOL of AD and dementia patients and caregivers, which is just
as valuable as the latest drug developments, perhaps even moreso.
The discourse surrounding AD and dementia in our society can be broadly classified as
pertaining to either one of two categories: “The Dread” and “Science as the Holy Grail”. When
talking about AD and dementia, the first thing that comes to mind for many people is how
prevalent these illnesses are becoming. Prevalence does not necessarily need to be defined by
statistics. In everyday conversation, AD and dementia prevalence is increasingly noticeable. It is
not uncommon to bring up AD and for someone to say something like “my friend’s grandpa had
that” or “my grandma currently suffers from AD.” After someone suffering from the disease is
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identified, the conversation might continue until someone says something along the lines of,
“yes, it’s been awful watching them deteriorate” or “taking care of them has been extremely
difficult.” Not to say that it should be, but the conversation is never really pleasant. It is, more
than anything, sad and surrounds the devastation of having a loved one or knowing someone
who is affected by dementia.
Countless videos on YouTube exploit the sadness of AD. The title of the video is almost
always “Jane Doe’s Story: Living with Alzheimer’s Disease.” These videos usually show clips of
the patient with AD exhibiting some of the classic symptoms, confessional style footage of the
family members detailing how long it has been and how sad it makes them to have to watch their
loved one completely change, and confessional style footage of medical professionals giving
scientific facts about the disease. The goal of these formulaic videos is to gain sympathy from
the audience. The formula works. These videos are tear-jerkers, for sure. However, the
devastating narrative that is portrayed does not acknowledge the happiness in between the
sadness. The journey that patients affected by AD and their caregivers go through is not
sorrowful the entire time. As unlikely as it may seem, there are moments of appreciation,
laughter, and gratitude, woven in throughout the duration of the illness.
In this society, we tie self worth with cognitive function. If cognitive function is lost, the
individual loses their ability to produce. Therefore, their worth and the value that they should
inherently have is diminished. It only makes sense that people would fear getting AD in response
to this phenomena. In the preface of his book Self, Senility, and Alzheimer’s Disease in Modern
America, Jesse F. Ballenger details his experience working as a nursing assistant in the 80s and
explains how “the destruction of brain tissue [associated with AD] entail[s] a destruction of
abilities and qualities essential to people’s identity, if not to their very humanity”, which he
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witnessed in some of his own patients (Ballenger ix). Ballenger also provides insight into how
people with AD are often described by others: “as ‘hollow shells,’ as ‘no longer really there,’ as
having somehow already died despite the troubling persistence of an animate body” (Ballenger
x). Such a description can be really disheartening, especially for caregivers. If the patient is ‘no
longer really there’, then who are they working to keep alive? Who are their blood, sweat, and
tears, serving? A memory of someone who used to be? Keeping the mere memory of a person
alive should not demand this much effort.
From the get-go, Ballenger claims that the dread surrounding dementia, “has helped to
shape knowledge about dementia, health policy, and the experience of caregivers and people
with or at risk for dementia” (Ballenger 1). The dreadful story that has been created for AD over
time has real-life implications. Limiting the characterization of an illness to only being able to be
thought of as depressing and grief-inducing affects the kinds of options and opportunities that are
available to patients and their families. Moreover, changing the discourse to one that is more
accurate and well-rounded would aid in efforts to humanize AD patients and allow them to live
with dignity. To be clear, the goal is not normalization. Dementia should never “be considered a
potentially natural part of growing old” (Zimmermann 394). All the money and effort going
towards one day finding a cure would be in vain if that was the case. People dedicate their whole
lives to finding a cure, whether that be through science or activism. Losing oneself should not be
what people prepare for as they age. Instead, the new narrative should be all encompassing. It
should include fear, dread, sadness, and the moments of joy, humor, and peace.
Given the depressing nature of the dialogue surrounding AD and dementia, people need
something to hope for, something to look forward to. Science fills that void. On the AA’s
website, one of the listed ways for good Samaritans to “get involved” is to advocate for research
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funding. There, they literally state: “Alzheimer’s is a devastating disease impacting millions of
families and our nation’s economy. The only way to change this is through research.”
(Alzheimer’s Association). The language used by the AA positions science to be viewed as the
end all be all for AD. By positioning science as the only means for change, it becomes easy for
other change-making methods to be disregarded or ignored. In isolating research outcomes as the
only entity that AD patients and families have to be hopeful about, science becomes, what I call,
the holy grail.
As briefly mentioned in the preface, the NIH alone spends billions of dollars every year
on AD research. Considering how heavily funded AD is, one would think that there would be
more treatment options for AD patients. Research is expensive, time-consuming, and does not
always supply significant results. In the 2018 article “Asking the Right Questions in Alzheimer’s
Research”, Susan Fitzpatrick accurately summarizes the true effects of putting science on a
pedestal as the primary path towards a solution to the AD-dementia problem:
Forty years into a full-on effort to defeat Alzheimer’s disease as a major cause of
cognitive decline and death—indeed, it is the sixth leading cause of death in the United
States, afflicting nearly six million people and wreaking enormous emotional and
financial tolls on patients and families—this is where things stand: we have no
treatments, and though efforts to improve early-stage diagnosis have had some success,
their main impact is to inject enormous new uncertainties and anxieties into a patient’s
view of the future and sense of self (Fitzpatrick 77).
Of all the resources we have to aid the patients and families dealing with dementia, the majority
of them go towards science. The idea is that science will solve all our problems. We are supposed
to believe in how the next study, the next drug, the next therapy, will drastically change the lives
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of AD patients and their families. The reality is that there is no guarantee that there will be a new
drug or therapy. Even if there is one, there is no guarantee that it would actually be accessible to
that many AD patients. Putting all faith into science is misleading and leads to disappointment
for all the AD patients and families that are really depending on potential scientific innovation.
Regardless of the unimpressive outcomes that technoscientific developments might offer,
that seems to be the first place that people turn to for answers and solutions. The environmental
sociologist, Laurent Cilia, writes about a similar problem as it pertains to bees and beekeepers. In
his 2019 article, ‘We don’t know much about Bees!’ Techno-Optimism, Techno-Scepticism, and
Denial in the American large-scale Beekeeping Industry, Cilia plainly defines
“techno-optimism” as “the faith in technology and science” which was originally derived from
Enlightenment philosophers’ “call for reason” (Cilia 85). Cilia explains how beekeepers have
leaned into techno-optimism, and techno-imaginaries in general, since the survival of the bees
directly affects their own livelihoods (Cilia 85). Referencing a study done by Kulhanek et al.,
Cilia acknowledges that “science has made little if any measurable progress on the global health
of honey bees since the beginning of the [Colony Collapse Disorder] crisis in 2006 [but] losses
remain concerningly high, [begging] the question of whether this is the right approach to the
issue” (Cilia 85).
AD patients, families, and caregivers, are implored to fall into the same unsubstantiated
techno-optimism. Much like with honey bee health, science has made little progress on
understanding why and how dementia occurs, let alone how to treat it. Medications doctors
prescribe to dementia patients are generally antidepressants and/or antipsychotics.
Dementia-specific drugs still do not exist. Because of the insanely complicated and long process
that it is to develop medications, there is no use in waiting around for that to happen. While we
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wait, people are still suffering and the daily struggles of living with AD or living with a loved
one that has AD remain unaddressed. Moreover, relying on the development of new medications
as the only potential remedy to the dementia problem disregards a more holistic approach at
treating dementia.
The truth is that AD and dementia is sad. There is currently no way to prevent the
unraveling of the mind caused by such neurodegenerative diseases. However, we must consider
the direct material implications that this dreadful narrative cultivates. If there is no solution to a
problem and it is going to be devastating no matter what, then what is the point in devoting
resources to that problem? Limiting the way that AD is thought and talked about, in turn, limits
the options available to patients and families. As a society, we must get creative and think
outside of the scientific box that we sometimes put ourselves in. Only then does the experience
of patients and caretakers alike have the possibility to improve.
Before all else, it is imperative that an individual’s worth is untied from their cognitive
function. Thinking about personhood in the context of mental status is unjust and outdated.
Every life has inherent value regardless of a person’s mental or production capabilities. I will be
exploring this idea through the analysis of William Utermohlen’s art, specifically a selection of
some of his self-portraits. Additionally, there is strength in AD patients, caregivers, and families
telling their own stories. Personal stories can do so much for the healing of those that know the
loss of neurodegenerative illnesses; it is crucial that they know they are not alone and that their
experiences are not isolated ones. In an examination of Sarah Leavitt’s graphic novel, Tangles: A
Story About Alzheimers, My Mother, and Me, I am seeking to convey the merit that storytelling
has in bettering the QOL for all those affected by AD and dementia.
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Background
Dementia is an umbrella term used to describe a group of neurodegenerative illnesses that
impair the ability to think, remember, and make decisions (Alzheimer's Association). AD is the
most well-known kind of dementia because it accounts for 60-80% of all dementia cases
(Alzheimer's Association). AD is arguably the most talked about and heavily funded form of
dementia, as well. The Alzheimer’s Association has contributed to this by doing an especially
good job at raising awareness about AD over the years. What isn’t well known about AD are the
origins of the disease.
Progressive cognitive impairment, a hallmark characteristic of AD, is a pattern that has
been identified and associated with elderly patients, stretching back centuries (Ballenger et al.
47). Dementia as a whole was characterized by clinicians about fifty years prior to “Alzheimer’s
time” (Ballenger et al. 47). Yet, AD, specifically, could not have been fleshed out as a scientific
concept until the early 1900s because certain processes needed to be invented to make AD
definition possible, such as the development of “techniques to preserve the brain for examination
and to process tissue in a way that microscopic evaluation could be conducted” (Ballenger et al.
48). Thus, AD couldn't have been detected or defined prior to Alois Alzheimer’s lifetime. The
man that the disease is named after needed to grow up and finish his studies before his curiosity
and ingenuity would lead him to the patient case report that would result in his surname being
commonly referred to, for so many decades after him.
Following his graduation from medical school in 1888, Alois Alzheimer went to the
Municipality Asylum for the Mentally Sick and Epileptics in Frankfurt, Germany where he was
mentored by the “liberal psychiatrist” Dr. Emil Sioli (Ballenger et al. 6). Alzheimer ended up
becoming very interested in psychiatry himself and found himself eager to incorporate his love
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of microscopy into the field (Ballenger et al. 6). The opportunity arose when “the number of
mentally ill patients [began to increase rapidly] in Germany” and Dr. Franz Nissl came to
Frankfurt after discovering “better tissue-staining techniques” (Ballenger et al. 6). The friendship
that Alzheimer and Nissl formed in the 1890s after doing research together in Frankfurt helped
get Alzheimer connected to the psychiatry researcher Emil Kraepelin in Heidelberg (Ballenger et
al. 6-7).
Ultimately, Alzheimer went to Heidelberg to work on a research project with Kraepelin
after deciding that he wanted to try and combine his clinical work with research (Ballenger et al.
7). After developing this relationship with Kraepelin, Alzheimer followed him to Munich where
he would end up being the “head of the neuroanatomic laboratory” at “the Nervenklinik”
(Ballenger et al. 7). Nervenklinik ended up becoming a central place for many “renowned
psychiatrists and neuropathologists” to meet up and work on research together, including the
making of “thousands of microscopic preparations” (Ballenger et al. 8). His position at
Nervenklinik set the scene for Alzheimer to work with Gaetano Perusini, who would help him
write the descriptions about the first documented AD patient: Auguste Deter (Ballenger et al. 8,
10).
Auguste was “a 51-year-old woman from Frankfurt[, Germany]” who’s symptoms
included “progressive cognitive impairment, focal symptoms, hallucinations, delusions, and
psychosocial incompetence” (Ballenger et al. 5). After her death in 1906, “Alzheimer asked that
[her extensive patient] record and [her brain] be sent to Munich” where he would analyze the
brain in his lab and determine that August was also presenting “arteriosclerotic changes, senile
plaques, and neurofibrillary tangles” (Ballenger et al. 5, 19). In 1907, he held a lecture about his
case-study on Auguste, at the annual Southwest German Psychiatrists meeting in Tübingen,
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which was eventually published in a journal “under the title, ‘A Characteristic Serious Disease of
the Cerebral Cortex’” (Ballenger et al. 20). A few other reports came out after that discussing the
same disease and referencing his paper (Ballenger et al. 21). The culmination of these
publications later influenced Kraepelin to mention AD for the first time ever in “the eighth
edition of his Handbook of Psychiatry (1910)” (Ballenger et al. 21).
Despite the inclusion of AD in early 20th century publications, “none of the involved
psychiatrists… provided clear-cut definitions of” AD (Keuck 12-13). AD was only vaguely
described and the “‘peculiar [patient] cases’” meant to serve as evidence of AD’s discovery
could have also been considered “atypical forms of senial dementia” since AD was so loosely
defined at the time (Keuck 13). This left room for discussion about the validity of early AD
findings and much needed to happen before AD could become the so-called “social disaster” we
now know today (Ballenger et al. 49).
Through the early 1930s, the goal of clinicians then became to distinguish AD from
“normality” (Ballenger et al. 48). Apparently, the “histopathologic study of brain tissue [was not
enough] to establish solid ground for this distinction” (Ballenger et al. 48). In the 1940s and
1950s, psychosocial approaches to dementia were of primary interest but those methods were
withdrawn in the 1970s when “biological models” became resurgent and tools like electron
microscopy and neurochemistry were more widely available (Ballenger et al. 49). The shift
towards biology-centered means of understanding AD might also explain why AD “was rarely
diagnosed until the mid 1970s” (Keuck 11). The 1980s marked when AD “began to be ranked
among the ten most common causes of death in the United States” (Keuck 20). In the 21st
century, genetics has taken over and that is the lens by which AD is looked at now (Ballenger et
al. 50). The development of Sanger sequencing, and its commercialization in 1986, allows for the
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identification of specific sequences in DNA (Wikipedia). With the use of Sanger sequencing in
and through the operation of the Human Genome Project (1990 to 2003), researchers are able to
compare specific DNA sequences in order to assess an individual’s genomic mutations against a
norm. Continuing into the present, the predominance of genetic understandings of disease have
meant that approaches to AD are focused on analyzing genetic inheritance and developing
genetic therapies and interventions. Aside from the metamorphosis of AD conceptions over time,
socially and scientifically, the suffering that AD has inflicted on so many generations of people
remains constant.
In the preface of this paper, I briefly mentioned that my grandmother suffers from LBD.
The choice to center my research on AD and dementia in general, as opposed to having a focus
on LBD, stems from LBD not being as well known. LBD only accounts for 5-10% of all
dementia cases (Alzheimer's Association). Even though approximately 1.5 million people are
suffering from LBD in the US, it is still significantly less common than AD (Williams 1308).
Recently, LBD has gained some kind of notoriety after the passing of the beloved actor, Robin
Williams, in 2014, who was devastatingly affected by this illness. As a matter of fact, I recently
suggested to my systems neuroscience biology seminar professor that I wanted to do my
semester presentation on LBD and he replied “Oh! Isn’t that the dementia that Robin Williams
had?” Still, the loss of the esteemed comedian and actor a number of years ago is not enough to
increase the public’s awareness of LBD to the same extent that AD is commonly familiar.
Research articles and books on AD are much easier to find. Because my argument is applicable
to all kinds of dementia, it is not necessary for all of my evidence to be specifically about LBD.
Nevertheless, it is important to point out that LBD and other dementias have their own unique
histories and hallmark features that differentiate them from AD.
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According to the IHME, neurological diseases, as a whole, accounted for approximately
2.21% of total DALYs in the year 1990 (see fig. 2). DALYs (Disability-Adjusted Life Years) are
a “measure of [the] burden of disease in a population” (Carlson, slide 6). DALYs are the
“number of years of healthy life lost in a population due to premature death and disability”
(Carlson, slide 6). By 2019, total DALYs, as a result of neurological diseases, have almost
tripled and account for about 6.16% of total DALYs overall (see fig. 2). AD and other dementias
alone accounted for 0.45% of total DALYs in 1990 (see fig. 2). By 2019, AD and other
dementias accounted for 2.19% of total DALYs (see fig. 2). In nearly 30 years, the percent of
global DALYs attributable to AD and other dementias has quintupled (see fig. 2).

Fig 2. IHME; “Global Burden of Disease (GBD) Study Results.” Institute for Health Metrics and
Evaluation, 2019, https://vizhub.healthdata.org/gbd-results; graph.
AD and other dementias are immense global public health threats. When looking at a
world map depicting DALYs from AD and other dementias in 2019, it is clear that the majority
of DALYs are concentrated in more developed countries, such as Japan, Canada, and Spain
(IHME). Even so, no one is guaranteed to have immunity from AD, even if the risk is extremely

Martinez 22
low for youths. For people with late-onset AD, symptoms usually start to appear in patients
during their mid-60s (NIA). Patients suffering from early-onset AD might start to experience
symptoms anytime betweens their 30s to mid-60s (NIA). There are several stages of AD and
symptoms vary according to the stage that the patient is at but some of the most common
symptoms of AD are memory loss, wandering and getting lost, and difficulty communicating
(NIA). People from all races and ethnicities can develop AD (AIM). However, like with every
disease, there are disparities in terms of what groups face a higher risk. Based on data from a
collection of studies, “African Americans are about two times more likely than white Americans
to have Alzheimer’s and other dementias” whilst “Hispanics are about one and one-half times
more likely than whites to have Alzheimer’s and other dementias” (AIM).
The number of worldwide dementia cases is expected to grow at alarming rates in the
foreseeable future. IHME researchers at the 2021 Alzheimer’s Association International
Conference (AAIC) presented findings that estimate dementia cases to triple in the next 30 years,
going from “an estimated 57.4 million cases globally in 2019 to an estimated 152.8 million cases
in 2050” (Nichols and Vos). In their report, Nichols and Vos acknowledge how the projected
increase could largely just be due to a population that is growing and aging (Nichols and Vos).
Importantly, at last year’s AAIC, Nichols shared how she hopes these numbers will equip
“policymakers and decision makers [a more comprehensive understanding of] the expected
increases [themselves]…as well as the drivers [for] these increases” while also demonstrating a
heightened “need for research focused on the discovery of disease-modifying treatments and
effective low-cost interventions for the prevention or delay of dementia onset” (AAIC).
As cases of dementia grow, the urgency to find treatment options for AD patients, and to
learn more about dementia in general, will also grow. In turn, more pressure will also be put on
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the government to increase funding for neuroscience research, as has been happening for a little
over the last ten years. The policy most responsible for significant annual increments in
governmental AD research funding is the National Alzheimer’s Project Act (NAPA) which was
enacted in 2011 (AIM, Bayh). Even with access to tremendous monetary support, science has not
been able to determine a comprehensive understanding of what causes AD, much less facilitate
the output of treatment options that do anything besides symptom management. While there is
definitely a need for AD studies to continue being financed, it is unreasonable for this giant pool
of capital to be streamlined to one place, the one place being scientific efforts. Given the inability
of science to guarantee a meaningful output, the sensible course of action should be to
decentralize AD-designated resources (monetary or otherwise) and distribute them more
equitably.
Based on my research, I contend that goals for AD in the next ten years should aim to
diversify available treatment options for patients and to expand care options for caregivers and
families. One area that could be given more attention is the humanities. When mentioning the
humanities here, for the sake of this entire paper, I am referring to disciplines like “philosophy,
history, literature, art, classics, and music, among others” (SHC). Science champions tend to
dismiss these genres and are “eager to write off [humanities] disciplines as “soft,” subjective, and
therefore inferior to science and its rigorous approach” (Boehnke 1166). Sometimes the most
complex or rigorous approach is not the best approach. After all, in biology, the principle of
parsimony states that “the most acceptable explanation of an occurrence, phenomenon, or event
is the simplest [explanation], involving the fewest entities, assumptions, or changes” (Martin and
Hine). Moreover, the humanities should be viewed as a useful tool to “enhance the practice and
understanding of science, among scientists and the public” (Boehnke 1166). Instead of viewing
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the humanities as a competitor field, it should be viewed as an aid to the same goals science is
trying to achieve or the problems it is trying to solve.
Art therapy or music therapy, which employ the techniques of humanistic genres to treat
patients, are—as I term them—humanities-based approaches to illness. The result of these
therapies differs from what is expected of a medicative treatment but there are worthwhile
outcomes, nonetheless. Specifically in the context of AD and other dementias, art therapy has
been shown to affect patients by engaging their “attention, [providing] pleasure, and [improving]
neuropsychiatric symptoms, social behavior, and self-esteem” (Chancellor et al.). These kinds of
impacts are difficult to quantitatively measure but that is where the focus should shift to
qualitative evaluations. Do these therapies improve the QOL of the patient? Do they improve the
QOL of the caregiver(s)? Does it make living and dealing with dementia a little easier? If the
answer to any of these questions, after experimenting with a nontraditional (i.e. not intrinsically
scientific) treatment approach, is “yes”, then it is worth delving deeper into such methods.
Expanding what is considered “treatment” and making a variety of options widely available and
accessible to AD patients and their families could alleviate some of the daily struggles that
people face. This will be especially necessary as the number of communities afflicted by AD and
dementia grows and traditional treatment options become more limited.
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Alternative Therapies: Music and A Memorable Artist
As long as a particular disease is treated as an evil, invincible predator, not just a disease, most
people with cancer will indeed be demoralized by learning what disease they have.
— Susan Sontag, Illness as Metaphor
As soon as my grandmother started experiencing dementia symptoms, she simultaneously
began to lose her autonomy. It was as if her independence coiled up and slowly retreated as soon
as it felt the presence of the invincible predator, preying upon her mind (Sontag, 7). To add on to
the self-inflicted withdrawal, my family started to prevent her from doing certain tasks. In
response to the many plates of undercooked chicken and burnt rice, my grandmother was not
allowed to cook anymore, something she had done every single day, feeding our entire family,
for as long as I could remember. Eventually, there was very little that she did do.
While it is logical to prevent AD and dementia patients from engaging in activities that
would put them or others in harm's way (i.e. cooking and risking the start of a kitchen fire), I
argue that it’s important to have an active curation of relationships, activities, spaces, resources
that enable and encourage participation, relationship building, and expression. I have found in
my analysis of my own lived experience as well as close-readings of medical care practices and
literature depicting life with AD that, whether it is intentional or not, AD patients are often
excluded from their usual forms of social and relational behaviors and activities that they used to
have. They are not invited to the table, never mind the party. Sometimes, this is because they
ostracize themselves but it can be argued that others also purposefully omit them from social
situations or activities. People that do not, directly or indirectly, know someone suffering from
AD might not understand what it means to be around someone with cognitive impairment and
are more likely to adopt false understandings of what dementia patients can or cannot do and
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how they can or cannot participate. Thus, a common pattern I have encountered in the materials I
have analyzed is to not include AD patients in activities, conversations, and group events.
Normatively abled people cannot easily understand them and are inclined to be weirded out by
them, react to them with disgust, or simply ignore them. Yet, the default othering of people with
AD is really a missed opportunity to make living with AD as positive of an experience as
possible.
Ingunn Moser is a STS studies writer that has explored dementia care at great length. One
way that Moser has looked at dementia care is through “modes of ordering”, an idea she
extrapolated from John Law’s Organising Modernity: Social Ordering and Social Theory (Moser
707). Moser uses two main “modes of ordering to make an argument about politics and
normativity in STS”, the first being a somatizicing order which generally has “to do with the
soma, a matter of biology” (Moser 708, 711). This mode is analogous to the idea of “Science as
the Holy Grail” that I have discussed in detail in earlier sections of this paper. The second mode
is the relational order that works “to counteract or at least postpone [the] process of
disconnection” that dementia patients experience (Moser 716). Moser describes how “dementia
presents itself as a growing mismatch and problem with relations between the patient, the daily
environment and fellow beings”, which is what most people struggle to understand is what
happens as neurocognitive impairment progresses (Moser 714). This failure to comprehend what
is actually happening in AD stirs up the fear that is associated with dementia, otherwise known
as what I call “The Dread”.
Similarly to the case that I am trying to make here, Moser acknowledges how the
“relational approach does not deny the reality and objectivity of [dementia] but demonstrates a
different way of acting upon life and shaping ways of living and dying with dementia—within
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the medical world” (Moser 716). Thus, the relational approach presents an opportunity to
introduce nontraditional methods of dealing with dementia patients. In her paper, Moser uses
examples of Mrs. Olsen, a Norwegian nursing home dementia patient in her eighties, to really
make her case about the benefits of relational ordering (Moser 708). Moser shares how Mrs.
Olsen’s caretaker has incorporated music therapy techniques into her daily care routine “to create
a channel for contact, connection, and communication” (Moser 713). As is true for many AD
patients, Mrs. Olsen struggles to speak and when she is able to get words out, they aren’t
necessarily coherent (Moser 705). As such, music therapy in this scenario serves as an important
tool to “open up access to the person’s life history and [to] build connections to her life and her
self… through emotion, experience, and memory embedded in wider, more distributed and
complex forms” (Moser 713). This kind of connection is something that could not be achieved in
a somatizicing approach of care because it is not scientific in nature; it is humanistic. I
understand the relational approach of care to put forth an interactive framework, centered around
bridging differences in ability. The reciprocity of the relational approach gives AD patients the
opportunity to also be active agents in their interactions or, more generally, in the social world.
By sanctioning their choices in music and granting the space to sing along if they choose to,
music therapy acknowledges AD patients’ social agency. Likewise, having the opportunity to
depict themselves and their environment through art therapy allows people with AD to form an
engagement with and embody the world as they see fit.
A notable instance of someone who integrated some version of art therapy into their own
experience living with AD is William Utermohlen. Utermohlen was born in Philadelphia in 1933
where he would end up attending the Pennsylvania Academy of Fine Arts to study art (King 64).
He continued his studies in the late 1950s at the Ruskin School of Art in Oxford, England, which
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led to him settling in London, where he spent the rest of his life until his passing on March 21,
2007 (Boïcos and Norback). Utermohlen’s art consisted of “portraits, still lives, and drawings
from the model” but was thematically diverse, inspired by and changing synergistically with the
different stages and time periods of his life (Boïcos and Norback).

Fig 3. William Utermohlen; “Self Portrait”, 1967,
http://boicosfinearts.com/exhibitions/william-utermohlen-a-persistence.html; mixed media on
paper.
Utermohlen’s life changed in 1995, at the age of 62, when he was diagnosed with AD
(King 64). Still, he remained active and made art until he couldn’t anymore. Utermohlen
produced his last pencil drawings from 2000-2002, five years prior to his death at 74 years old
(Boïcos and Norback). While Utermohlen did not engage in conventional art therapy, his
dedication to his art and willingness to preoccupy himself, for over ten years after his diagnosis,
is a testament to the value of artistic expression in AD patients. Typically, AD patients live on for
“an average of four to eight years after [an AD diagnosis]” (Alzheimer’s Association 723).
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Utermohlen’s lifespan exceeded that of the average AD patient and, although it might be
frivolous to attribute his longevity to artistic expression alone, it wouldn’t be illogical to assume
that perhaps his artistic creations were a contributing factor to his relatively long life.

Fig 4. William Utermohlen; “Self Portrait - Two Sculls”, 1995,
http://boicosfinearts.com/exhibitions/william-utermohlen-a-persistence.html; pencil on paper.
Utermohlen’s ability to produce more than 20 self portraits (from what is posted on the
Chris Boïcos Fine Arts website) over the course of his illness is not only a testimony to his own
initiative but it is a look into the kind of support system that he had around him at that time. His
wife, Patricia Utermohlen, shared how he would show each completed self portrait to his nurse,
who would proceed to visit the studio and photograph every new work, because he believed that
“William’s efforts were helping to increase the understanding of the deeply psychological and
traumatic aspects of the disease” (Bahadur). To continue creating, Utermohlen needed to be
encouraged, motivated, and somewhat inspired, which are all factors largely influenced by the
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kind of people one has in their surroundings. AD patients are undoubtedly difficult to deal with.
They can behave in unexpected and, sometimes, violent ways. People that are intolerant or
unsympathetic to what AD patients are going through might consider their “bad” or atypical
behavior as reason to exclude them or prohibit them from partaking in certain activities. On that
account, it is crucial that their support network is made up of people that already are, or are
willing to learn how to be, patient, compassionate, inclusive, and uplifting. While perfection (i.e.
never losing patience) is an unrealistic expectation, it is important that AD patients have access
to a support network that really tries their best to show them love and make their environment a
positive place to be in.

Fig 5. William Utermohlen; “Self Portrait - Head I”, 2000,
http://boicosfinearts.com/exhibitions/william-utermohlen-a-persistence.html; pencil on paper.
The work of William Utermohlen is representative of more than just his own desire to
remain useful and the community of people around him that made his work possible. His art acts
as a window, looking into the inner workings of his mind as AD dominated it. Evidence of AD is
“apparent in the shifting perceptions of space, objects, and people” (Boïcos and Norback). As the
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images progress, the location of his head on the page starts to migrate off-center (see fig. 5).
Compared to the self-portraits he made preceding his AD diagnosis, the way Utermohlen draws
his skull changes in length (see fig. 3). The skull starts to appear more elongated, as if it was
growing or the weight was shifting towards the posterior or dorsal side of the body (see fig. 4).
Additionally, more lines are drawn in places that form ridges in the skull that were not previously
depicted (see fig. 4 and fig. 5).
One of the more obvious modifications is the loss of facial feature definition as time
progresses, which could be an indication of “a progressive loss of identity or sense of self” (see
fig. 5, King 65). After five years of AD wreaking havoc upstairs, Utermohlen’s self-portraits start
to lack eyes and eyebrows (see fig. 5). The facial features that did make it onto the face—such as
the ear, nose, and mouth—have drastically lost precision and look nothing like the
extraordinarily skillful portraits he had composed in the past (see fig. 5). Rather, they appear
more disfigured and blob-like, and are not aligned realistically on the face (see fig. 5).
Utermohlen’s portrait drastically deviates from classic representations of what a face “should”
look like which can evoke feelings of unease, disgust, or repulsion in viewers. Nevertheless, this
is not surprising due to “the loss of facial recognition that is often [a symptom] of AD” (King
65). In the ways described above, Uterlmohlen’s art becomes a communication tool for the many
symptoms he is experiencing but cannot articulate. It allows him to be transparent about what he
is going through with the people around him without having to dig through his jumbled up
thoughts, on a quest for the right words.
The effort required to incorporate art therapy into a dementia patient’s routine is
worthwhile. Giving patients an opportunity to spend time with their imagination and make
something tangible is as a way of returning some of their autonomy back to them. Art therapy
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tasks give dementia patients authority over an unspecified deliverable and “can help reduce the
feelings of isolation and loneliness that accompany AD” (King 66). In theory, art supplies and
proper supervision are all that would be vital to the execution of an art therapy session for AD
patients. Compared to the cost of the research that is fundamental to generate a pill that results in
similar effects (i.e. reduced feelings of isolation and loneliness), art therapy is a way more cost
and time-effective means of improving the QOL of AD patients.
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Tangles
Tangles: A Story About Alzheimer’s, My Mother, and Me is exactly what the title
describes. Sarah Leavitt introduces the reader to her mother, Midge, and tells us the story of her
life from beginning to end, primarily focusing on life after the AD diagnosis. Like most people
with loved ones affected by AD and dementia, Leavitt loved her mother and watching her
mother’s decline, even if from afar, was painful. Despite the striking depictions of grief and
sadness that Leavitt accurately captures in her work through illustrations and anecdotes, reading
her graphic novel was a comforting experience.
AD representation in something other than a scientific journal or the AA website is
sometimes hard to come by. Leavitt’s honesty and willingness to share even the worst of her
thoughts while helping to care for her mom with AD is refreshing and relatable. The personable
nature of a story from a daughter who understands the deep pain associated with losing a loved
one to dementia, otherwise known as an AD memoir, is reimagined in a visual-heavy format. Not
only is reading this book a necessary experience that all AD-affected-families and caretakers
should have access to, but it is a great resource for people unaffected by dementia to actually
envision what it might be like. There is so much healing potential in artistic depictions of
horrendous mind conditions that are otherwise “invisible”, unlike a fractured bone or a skin rash,
for instance. Of course, AD is not completely invisible as it is very much apparent in the
behavior of the patient. However, there is an invisibility aspect in the care that AD demands from
caregivers. Being represented in art and knowing that one’s experience is not an isolated one
allows for a transparency that is alleviating and, hopefully, can make peoples’ experience in
caring for a loved one less burdensome.
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Fig 6. Sarah Leavitt; “Midge suspects she “[has] Alzheimer’s.” Tangles: A Story About
Alzheimer’s, My Mother, and Me, 2012, graphic novel panel.
Leavitt shares many anecdotes with us but one that particularly caught my attention was
of the time that she and her girlfriend visited her parents in “Sunny Mexico” after Midge
revealed that she possibly has Alzheimer’s (see fig. 6). The contrast between the panels of their
visit to “Sunny Mexico” and the singular panel of Midge saying “I have Alzheimer’s” is quite
compelling (Leavitt 25, 28-29). The revelation that Midge probably has AD is one that is hard to
accept for all members involved in that conversation, including Midge. At this time, she is not so
far along in the progression of her disease which means that she is aware of the ways in which
she is changing. The way that Leavitt has drawn her face in this panel with a dismal expression
and bags under her eyes is representative of that hard pill to swallow and the intense worry she
may be feeling (Leavitt 25). The all-black background is symbolic of the loneliness that Midge
likely feels at the beginning of her cognitive impairment journey and how the realization of what
is happening to her can feel all-consuming (Leavitt 25).
Arguably, the very beginning of the disease is one of the hardest times in a patient’s life
because of the occasional awareness they have of what is happening to them. Patients might be
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cognizant of the changes they are going through but they also have the knowledge that there is
absolutely nothing they can do to change their inevitable fate. Moreover, this time of severe
hopelessness is accompanied by the awareness of how their family is responding. The
unfortunate truth is that families do not usually have the best responses to the strange behavior
that patients experience during the onset of AD symptoms. Families might be angry, frustrated,
or confused, when their loved ones start acting unlike they have ever acted before. These
external responses that the patient cannot control only heightens the deep fear, solitude, and
suffering that the patient is already going through.

Fig 7. Sarah Leavitt; “Midge sits contently on some stairs, reflecting on her Mexico trip.”
Tangles: A Story About Alzheimer’s, My Mother, and Me, 2012, graphic novel panel.
The disclosure of Midge’s possible AD diagnosis is immediately followed by the family’s
trip to Oaxaca, Mexico which is made up of several panels where Midge appears somewhat
joyful (Leavitt 28-29). The black and white illustrations contrast the vivid descriptions of the
family’s activities while on vacation. The expressions of contentedness on Midge’s face
symbolizes her attempt to make the best of her situation and to try and enjoy herself despite the
AD related obstacles that have now begun to present themselves. The last panel on page 29
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closes with the powerful sentence “[Midge] loved the way that Mexicans remembered and
attended to their dead” which interestingly distinguishes the way that departed loved ones are
treated in Mexican culture compared to American culture, for instance (see fig. 7).
Perhaps unintentionally, Leavitt alludes to how there are differences in the way other
cultures treat their elderly. In American culture, it is common for elderly folks to stay living by
themselves until it becomes unsafe for them to do so. At that point, it is acceptable for families to
help elders move into a nursing home or assisted living facility. On the other hand, in Latino
culture, living in an establishment, such as the ones listed above, is far from the norm. For Latino
elderly, it is customary to go live with their family after they cannot continue living on their own.
Consequently, a family member(s) generally takes on the responsibility of being a designated
caregiver and is entrusted with the wellbeing and safety of the elder.
More often than not, this kind of care is informal, meaning it is “unpaid help from family
and friends” (Weiss et al. 146). In a 2004 study looking at discrepancies in the receipt of informal
care by disabled people aged 70 or older in the U.S., researchers found “a significant association
between informal home care and ethnic group, with 44.3% of Latinos receiving informal care,
compared with 33.9% of African Americans and 24.6% of non-Hispanic whites ( P<.001)”
(Weiss et al. 146). Marginalized communities, like Latinos, are “at [a] higher risk for poor health
outcomes due to higher rates of poverty and lower rates of health insurance coverage than
non-Hispanic Whites” (Weiss et al. 146). It only makes sense to infer that marginalized
communities are also less likely to be able to afford formal care options for their elders. On
average, families that pay for formal care (i.e. paid family caregivers) incur an average of $7,242
annual out-of-pocket expenses (Skufca and Rainville). Leavitt implicitly points out how Latinos
might attend to their elders more closely than other groups but it is important to consider the
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many reasons why that may be. “Cultural values and norms regarding responsibilities toward
elders” contribute substantially to how Latino families decide to care for their loved ones but
“level of disability and disease and socioeconomic status” also present barriers to the options that
are available to marginalized communities (Weiss et al. 148). Thinking about alternative care
options could offer opportunities to—at least partially—circumvent the social and economic
obstacles that marginalized communities disproportionately face.

Fig 8. Sarah Leavitt; “The ground crumbles underneath Sarah and Rob as the doctor confirms
Midge’s diagnosis.” Tangles: A Story About Alzheimer’s, My Mother, and Me, 2012, graphic
novel panel.
After the family returns from Mexico, they end up visiting the neurologist. Following a
series of questions and examinations, the doctor reaches a diagnosis: Alzheimer’s. Upon hearing
those words, Leavitt illustrates the ground literally crumbling underneath her and her dad (see
fig. 8). Their two bodies are positioned ever so slightly leaning forward in disbelief (Leavitt 37).
Their slanted eyebrows convey the heartbreak they are feeling after hearing such dismal news
(Leavitt 37). In her depiction of Midge sitting in a chair, enduring a series of seemingly easy
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questions being thrown at her, Leavitt denounces the insufficient and almost arbitrary tasks that
are completed to arrive at an AD diagnosis (see fig. 9). The fearful expression on Midge’s face
signals how the questions are actually challenging for her and how she feels pressure to answer
them accurately (see fig. 9). Leavitt also includes a panel of herself with an angry expression on
her face, imparting the frustration she felt while listening to the neurologist interrogate her
parents (Leavitt 37).

Fig 9. Sarah Leavitt; “Midge faces a series of questions for her neurological exam.” Tangles: A
Story About Alzheimer’s, My Mother, and Me, 2012, graphic novel panel.
There is no doubt that diagnoses are often life changing and grief inducing, for both
patients and their families. No one wants to accept the inevitable decline of their loved ones.
However, acceptance is also influenced and made more difficult by the nature of how these
neurodegenerative illnesses are identified. Some of the methods used by medical professionals to
arrive at a diagnosis can be intimidating for patients. Us readers get the impression that the entire
experience feels very impersonal and insensitive.
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Fig 10. Sarah Leavitt; “Leavitt describes how an AD patient gets diagnosed.” Tangles: A Story
About Alzheimer’s, My Mother, and Me, 2012, graphic novel panel.
Leavitt gives a relatively in-depth account of what exactly an AD diagnosis is based on.
The panel in which she includes this explanation is one of the wordiest panels in the entire
graphic novel, up until this point. The simple picture of an empty human head surrounded by two
mini-paragraphs is difficult to ignore (see fig. 10). The rudimentary style of the illustration
makes it appear foreign, as if to communicate how little is actually known about the human brain
(see fig. 10). Leavitt points out the lack of “definitive” AD diagnostic tools (Leavitt 40). Leavitt
points out that diagnosis is based primarily on observations of “behavior and symptoms” (Leavitt
40). Even when a diagnosis is reached, it is a “probable diagnosis”, nothing is ever certain
(Leavitt 40).
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AD is not an easy conclusion to arrive at. There is no sample that can be taken, within
reason. There are no numbers, graphs, or lab results that give patients and their families a “for
sure” answer, which of course adds on to the inherently difficult work of learning to accept.
When one is battling the likelihood that their loved one has AD, it is easy to lean into the idea
that observations can be subjective. While neurologists are, obviously, trained professionals
whose observations are meant to be credible, they are still people and people can be wrong. At
the beginning, holding on to the chance that a neurologist’s diagnosis could be inaccurate is one
way that dementia patients’ families hold on to hope.

Fig 11. Sarah Leavitt; “Leavitt secretly hopes her ‘real’ Mom is still around.” Tangles: A Story
About Alzheimer’s, My Mother, and Me, 2012, graphic novel panel.
There is a phrase in Spanish that my mom always tells me—“La esperanza es lo último
que se pierde”—which translates to: “Hope is the last thing you lose.” Sometimes, the desire to
hold on to hope never leaves. After all, “hope is the thing with feathers” and is much more
lightweight than logic (Dickinson). Even after years of my grandmother having dementia, deep
down inside, I hope there is an immortal sliver of her, somewhere in her body. Sometimes, I
believe she is still in there. I have fooled myself into thinking her soul is hiding, and is only
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afraid to come out. Sometimes, the story changes and I fool myself into thinking she is trapped
but will escape one day. Whatever version I have somehow tricked myself into believing is
temporarily comforting.
Leavitt is remarkably successful at describing the necessary internal narratives that one
might imagine to cope with the truth of their loved ones’ irredeemable state. The stark portrayal
of Leavitt directly facing her “fake mom” with a look of fear or disappointment on her face
embodies how emotionally demanding it can be to confront reality (see fig. 11). The look of
appall on “real” Midge’s face in Leavitt’s dream bubble speaks to how much Midge has been
changed by AD and how the “real” Midge would disapprove of her own behavior (see fig. 11).
The contrast between Leavitt’s “fake mom” and “real mom” is also daunting (Leavitt 94). “Fake
mom” is pictured as having no eyes, no eyebrows, and seemingly incapable of making facial
expressions or having emotions (see fig. 11). “Real mom”, on the other hand, has eyes and
eyebrows and is able to sympathize with the predicament at hand (see fig. 11).
Leavitt’s ability to encapsulate the very real, and relatable, feelings and moments that
made up her mother’s journey with AD is a true gift to her readers. Her authenticity, and ability
to articulate the instances that are not usually easy to describe, makes reading Tangles a fulfilling
experience. Not only does Leavitt shed light on the less spoken-about, not-so-fun realities that
accompany taking care of someone with AD, but she incorporates the nonlinear disposition of
the course, which is not always well understood. Leavitt’s inclusion of the joyful and funny
moments that occur when caring for an AD patient aids in her construction of a well-rounded and
forthright personal account of her experience.
To properly contextualize Tangles, recognizing its status as an AD memoir is critical. AD
memoirs are characterized by “the witness’s yearning to retrieve a coherent sense of the past”
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(Simon 8). In Tangles, Midge is “not [offered her] own narrative of what [she was] experiencing,
unless [the] narrative [was] mediated by the witness writer”, which in this case is Leavitt herself
(Simon 8). Tangles is undoubtedly from the perspective of Leavitt but unlike other AD memoirs
that are inconsiderate of the AD sufferer’s point of view, Leavitt does draw attention to how
Midge could be feeling. She touches on topics regarding Midge’s personal losses: senses,
abilities, privacy, and appetite, amongst others. Either way, my intent is not to argue for Tangles’
superiority in comparison to other AD memoirs but to demonstrate its value in depicting the
experience of AD patients and families, outweighing its contribution to the voicelessness of AD
patients in literature (Simon 8). Tangles takes steps towards representing the struggle and making
it possible for caregivers and families to see themselves in a narrative about someone else going
through something similar.
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Conclusion
Through opportunities for patients to engage in cultural productions and
humanities-based approaches of managing AD and dementia, the QOL for patients, caregivers,
and families, has a strong potential to improve. Alternative therapies and storytelling are avenues
through which the sadness involved with caring for a loved one diagnosed with AD may be
alleviated. Currently, there is a questionable trust in science to deliver outcomes that lessen the
burden of the ongoing battle against AD. Moving forward, overreliance on time-consuming and
expensive research will not be sustainable, imploring the need to explore and expand the care
options available to AD patients.
As the number of AD patients continues to grow annually, thinking creatively about care
options will be fundamental to managing the cognitive impairment crisis. Formal care options
are expensive and, therefore, inaccessible to many. Solutions within the humanities can present
more affordable options for struggling families. Furthermore, broadening societal views on what
is considered treatment and what is not can change the scope of healthcare. To clarify, the scope
of healthcare is limited by who can administer care. If we change how we think about care, then
we must reexamine: who is qualified to distribute what kind of care? The politics of care with
relation to dementia will be affected by these broader questions addressing the scope of
healthcare and its delivery but these changes will not be confined to just one type of illness.
Other categories of illness will be impacted and this will ultimately lead to systemic changes in
medicine as a whole.
To compensate for the speed of science, or lack thereof, alternative treatment and care
options will further demonstrate their worth. Science’s failure to provide outcomes will force
society to ponder questions about techno-optimism and why it is so deep-rooted in the first place.
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Simultaneously, social and political movements promoting distrust in the scientific community,
especially over the last few years, will only fuel the skepticism. Perhaps, the dire need to regain
the trust of society (i.e. whom science serves) will compel the scientific community to reevaluate
the bureaucratic processes in place that unnecessarily elongate investigations.
Since humanities-based treatments are not taken seriously, there is not much in the
literature about the real impacts they have on patients. This lack of evidence is also hindered by
the need to measure data quantitatively. Implementation of alternative methods will call for
future studies to explore the qualitative results of these approaches on patients’ lives.
Additionally, considerations need to be made about how to effectively incorporate alternative
care options into formal care settings, given how, as of now, they are only typically integrated
into informal care situations.
People that have a say over the lives of AD patients, such as their caregivers and families,
need to review what their priorities of care are. When thinking about care, it is not uncommon to
only mull over ways to subdue symptoms. Prioritization of symptom management in patients
with incurable diseases is pointless. Symptoms will never be completely “managed”. That is
assuming control over the disease, which in reality nobody will ever have. Instead, more
emphasis should be placed on QOL. How can we make living with AD a better experience? How
do we value the life of AD patients? Are we caring for them because it is a duty we have taken
on or because we want to? How can we appreciate their contribution to our lives and dedicate
efforts towards improving their living conditions? Reframing our answers to these questions will
facilitate changes in our mindset towards patients who need help to live.
Music is one modality through which mutual engagement with AD patients can be
organized. While spending time with my grandmother, I have searched up Cuban music from the

Martinez 45
1950s and 60s and every so often, a song will play that will inspire her to sing along. Sometimes
she will not necessarily make a sound but she will mouth the words. I will go ahead and try
another song to see what other responses I can provoke. Over time, I have curated a playlist of
some songs that I know she can identify and enjoy. These songs serve as a meeting space for my
grandmother and I. They enable her to be present with me, for us to be in relation with each
other, and to share quality time together. Finding other modalities that also help construct
meeting spaces for AD patients and other people to connect will be vital in the battle against AD
moving forward.
Spanish cartoonist, Paco Roca, is another person who is continuing the work of AD
representation through a graphic narrative. In the 2008 graphic novel titled Arrugas, Roca
provides a fictional story, though based on real people and real events, about a man named
Emilio who gets diagnosed with AD and his son chooses “to move him into a transitional care
facility” (Fraser 139). Like Tangles, Arrugas affords readers a space to appreciate “the unique
aesthetic aspects of visual narrative [which] allow us to understand the material experience of
[AD] within a collective and social framework that folds the clinical back into the non-clinical,
everyday, social experience of cognitive disability” (Fraser 169). Tangles and Arrugas are both
examples of the power in the visual modality of storytelling (Fraser 169). Storytelling has
healing properties and is worth considering when it comes to making resources available to AD
patients and families.
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Fig 12. Benjamin Fraser; “Emilio’s point of view over a meal; panels from Arrugas by Paco
Roca” Sequencing Alzheimer’s Dementia: Paco Roca’s Graphic Novel Arrugas (Wrinkles)
(2008), 2018, graphic novel panels.
Hallucinations are part of the long list of dementia symptoms. My grandma is always
talking to someone else. My words don’t necessarily get through to her because she is
preoccupied with her own conversations. She is essentially living in a different universe and
having differing experiences of the world. Watching TV is one way for her to be grounded in the
same reality as I. When she is in front of the TV, that’s when she reacts—colorful moving
images, cartoons, and animated movies capture her attention. She will laugh really hard, or
exclaim, or say something. Our planes of reality intersect here—when we are both watching TV.
There is a moment where it feels like we are both experiencing and reacting to the same thing,
together. In this way, visual modalities evoke a response that words cannot. TV and other visual
productions offer a way for my grandma and I to meet, to exist in unison, and share an
experience.
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Visual modalities are another means of generating connections. The visual creates a space
for “those who seem unable to tell stories” to consciously or unconsciously immerse themselves
in an imaginary that others have a stake in (Fraser 169). Moreover, visual productions traverse
cultural barriers and leave room for interpretation of all viewers. Even if Arrugas was not
translated into other languages (i.e. the English translation, Wrinkles), I am confident in its ability
to reach people globally just based on the universal messages communicated by the illustrations.
Albeit, the uniqueness of the graphic novel format stems from its marriage of the visual with the
narrative. Narratives about AD in a variety of languages are essential to increase accessibility of
relational and culturally diverse approaches to care. The significance of Arrugas being made
available in other languages and being successful in multiple parts of the world “confirms that
Spain is not alone in facing the issues raised by an increasingly aging population: the matter of
Alzheimer’s disease has global resonance” (Fraser 141).
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